Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
113 CHF | +15.31% | -.--% | +15.31% |
May. 31 | Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says | MT |
May. 31 | Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130 | MT |
Official Publications
SEC Filing 10Q-1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
Dividends | CO | |
SEC Filing 13G | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
Changes in management and corporate officers | CO | |
Dividends | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
Minutes of the general assembly | CO |
- Stock Market
- Equities
- ZBH Stock
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Official Publications